Amniotic gel could patch macular holes without complex surgery
NCT ID NCT06433284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new gel made from donated amniotic membrane to treat large macular holes, a condition that blurs central vision. The gel is injected into the eye during surgery to help close the hole. Researchers will compare this method to the standard flap technique in 26 adults. The goal is to see if the gel works as well or better, with fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- decellularized human amniotic membrane hydrogel
- What this could lead to
- If it works, this could offer a safer, easier way to close large macular holes and improve vision without the need for complex flap surgery.
- What could go wrong
- This is a small, early-stage trial with only 26 participants. The hydrogel is new for eye surgery, so its safety and effectiveness are not yet proven. There may be risks like infection or inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR HOLES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jakkrit Juhong
RECRUITINGNakhon Si Thammarat, Thasala, 80160, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.